Literature DB >> 445760

Reentry within the atrioventricular node: surgical cure with preservation of atrioventricular conduction.

E L Pritchett, R W Anderson, D G Benditt, J Kasell, L Harrison, A G Wallace, W C Sealy, J J Gallagher.   

Abstract

Paroxysmal supraventricular tachycardia (PSVT) is commonly caused by reentry within the atrioventricular (AV) node. This arrhythmia was abolished by operative dissection of the AV junction in a patient with disabling tachycardia that was not controlled by drugs. The operation was intended to create complete AV block, but AV conduction persisted after surgery. An electrophysiologic study 1 year after the operation revealed that the operation changed AV conduction in both the antegrade and retrograde directions, which may explain the absence of tachycardia. The patient has been free of arrhythmias for 18 months.

Entities:  

Mesh:

Year:  1979        PMID: 445760     DOI: 10.1161/01.cir.60.2.440

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

1.  Surgical treatment of tachycardias in preexcitation syndromes.

Authors:  W C Sealy
Journal:  Tex Heart Inst J       Date:  1982-12

2.  Slow potentials and catheter ablation for AVNRT.

Authors:  M Haïssaguerre; D C Shah; P Jaïs
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

3.  Closed chest modification of atrioventricular conduction system in man for treatment of refractory supraventricular tachycardia.

Authors:  G Critelli; F Perticone; F Coltorti; V Monda; J Gallagher
Journal:  Br Heart J       Date:  1983-06

4.  Cryosurgical modification of the atrioventricular node for treatment of atrioventricular junctional reentrant tachycardia.

Authors:  E C Perin; F Petersen; C Rizo-Patron; D A Ott; A Massumi
Journal:  Tex Heart Inst J       Date:  1991

5.  Surgical management of dysrhythmias in infants and small children.

Authors:  F A Crawford; P C Gillette; C L Case; V Zeigler
Journal:  Ann Surg       Date:  1992-09       Impact factor: 12.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.